logo

TRAW

Traws Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.44 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is TRAW a Good Buy Right Now?
  • Based on a composite score of 4.44/10, we rate TRAW as a Netural. Our analysis breaks down into 5.43/10 for Fundamentals, 5.14/10 for Technicals, and 3.60/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is TRAW undervalued or overvalued?
Technical Analysis of TRAW?
Is money flowing into or out of TRAW?